- 收听数
- 0
- 听众数
- 8
- 最后登录
- 2025-1-7
- QQ
 - UID
- 9301
- 阅读权限
- 10
- 帖子
- 1191
- 精华
- 0
- 在线时间
- 380 小时
- 注册时间
- 2014-5-1

- 科研币
- 2
- 速递币
- 25
- 娱乐币
- 1820
- 文献值
- 0
- 资源值
- 0
- 贡献值
- 0
|
5速递币
题名 | 9035 POSTER A National, Multi Center, Randomized, Open-label, Phase II Study of Erlotinib Versus Gemcitabine (GEM) Plus Cisplatin as Neoadjuvant Treatment in Stage IIIA-N2 Non-small-cell Lung Cancer (NSCLC) Patients (pts) With Activating EGFR Mutations (C-TONG 1103) | 链接 | http://www.sciencedirect.com/science/article/pii/S0959804911723474 |
|
|